Document is current
Any future updates will be listed below
-
Authors
Morohashi, Hajime
Sakamoto, Yoshiyuki
Miura, Takuya
Kagiya, Takuji
Sato, Kentaro
Tsutsumi, Shinji
Takahashi, Seiji
Nakayama, Yoshihito
Tamba, Hiroaki
Matsumoto, Shuntaro
Kasai, Daiki
Hakamada, Kenichi
- License Information
-
More Information
Article History
Received: 1 December 2023
Accepted: 3 December 2024
First Online: 18 December 2024
Declarations
:
: This study evaluated the feasibility and efficacy of S-1 and oxaliplatin neoadjuvant chemotherapy with total mesorectal excision and lateral lymph node dissection for rectal cancer. The strategy was determined to be a feasible and promising treatment option for rectal cancer.
: The authors declare no competing interests.
